Has David Pate, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,986 in general payments to David Pate, MD across 378 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Pate, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Pate, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Pate, MD

Dermatology · Slidell, LANPI 1255697090

Payments from drug & device makers

$7,986in general payments, 2019–2025

Across 378 payments — averaging $21.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Sanofi$1K
Johnson & Johnson$803
Organogenesis Inc.$653
UCB, Inc.$646
Regeneron Healthcare Solutions, Inc.$542
plus $3K from 21 others

What the payments were for

Food & beverage$7,72497%
Education$2623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	101	$1,636
Sanofi	58	$1,127
Johnson & Johnson	32	$803
Organogenesis Inc.	13	$653
UCB, Inc.	31	$646
Regeneron Healthcare Solutions, Inc.	31	$542
Pfizer	23	$540
Lilly USA, LLC	15	$307
Amgen	15	$289
E.r. Squibb & Sons, L.L.C.	8	$253
Incyte Corporation	9	$209
Sun Pharmaceutical Industries Inc.	10	$205
LEO Pharma Inc.	8	$163
Convatec Inc.	1	$119
Mayne Pharma Commercial LLC	7	$109
Sanofi-aventis U.S. LLC	1	$80
Novartis	3	$57
Medimetriks Pharmaceuticals, Inc.	1	$47
Almirall LLC	2	$44
Organon	2	$41
Dermavant Sciences, Inc.	1	$21
VYNE Pharmaceuticals Inc.	1	$18
Bristol Myers Squibb	1	$17
Bioventus LLC	1	$16
Verrica Pharmaceuticals Inc.	1	$16
Paratek Pharmaceuticals, Inc.	1	$16
Kerecis Limited	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,986 in reported general payments places this provider in the 60th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$506,378

Medicare patients

615

Services billed

3,319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	117	$2,204
Fluorouracil	30	$2,192
Triamcinolone Acetonide	153	$1,903
Clobetasol Propionate	46	$1,576
Doxycycline Hyclate	163	$1,541
Tretinoin	11	$985
Metronidazole	15	$555
Cephalexin	87	$275
Prednisone	15	$104
Acetaminophen-CodeineAcetaminophen With Codeine	23	$83
Fluconazole	12	$67

Paid to pharmacies, not to this prescriber.